EXHIBIT 10.9
AMENDMENT A
WHEREAS Physiometrix Inc. ("Physiometrix") and Xxxxxx Healthcare
Corporation ("Xxxxxx") entered into a STRATEGIC ALLIANCE AND EXCLUSIVE
DISTRIBUTION AGREEMENT ("Agreement") dated May 31st 2000, and both Physiometrix
and Baxter wish to amend the Agreement, the parties agree to amend such
Agreement as follows:
In line 4 of Section 11.3 of the Agreement, "To" shall be changed to
-- Starting in the calendar quarter beginning October 1st 2000, to --.
In witness whereof, the parties hereto have caused this Amendment to be
executed, in duplicate, by their duly authorized officers on the dates set forth
below.
Xxxxxx Healthcare Corporation Physiometrix Inc.
By: By:
--------------------------------- ----------------------------
Xxxxx X. XxXxx Signature
Title: Corporate Vice President and Title:
Deputy General Counsel ------------------------
Date: Date:
------------------------------ -------------------------